Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
As drug prices continue to rise, many U.S. hospitals are implementing aggressive strategies to reduce pharmaceutical spending, reports The Wall Street Journal.
The Food and Drug Administration will allow Pfizer to remove a serious warning from the label of its anti-smoking drug Chantix, reports Fox News.
Actavis could face fines for raising the price of its steroid treatment by more than 12,000 percent, reports Bloomberg.
Companies must untangle a complex web of factors when deciding not only where to locate a distribution center, but also how to run it, reports DC Velocity.
Tompkins International, a large-scale supply chain consulting firm, will take on a new role as a fourth-party logistics provider, reports DC Velocity.
Twenty U.S. states filed a lawsuit Thursday against six generic drugmakers, alleging they colluded to set fixed prices of two common drugs and split up market share, reports Reuters.
Kenilworth, N.J.-based Merck & Co. received $2.54 billion in royalties on Thursday through a patent lawsuit against Gilead Sciences' best-selling hepatitis C drugs Sovaldi and Harvoni, reports Reuters.
The generic version of Mylan's EpiPens will hit pharmacy shelves early next week.
Basel, Switzerland-based Novartis on Friday entered into a definitive agreement to acquire Ziarco Group.
McKesson Enterprise Information Solutions and Infor, a business application developer, have collaborated to form a strategic go-to-market partnership.